ID   ICC-X1
AC   CVCL_C2UP
DR   CCRID; 4201PAT-CCTCC02049
DR   Wikidata; Q123032653
RX   Patent=CN114606194B;
RX   PubMed=36578029;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202258.
CC   Population: Chinese.
CC   Doubling time: ~48 hours (Patent=CN114606194B; PubMed=36578029).
CC   Karyotypic information: Hypotriploid (PubMed=36578029).
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
ST   Source(s): Patent=CN114606194B; PubMed=36578029
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D12S391: 20,21
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 13,14
ST   D21S11: 31.2
ST   D2S1338: 22,24
ST   D2S441: 12
ST   D3S1358: 15,16
ST   D5S818: 9,10
ST   D6S1043: 10,12
ST   D7S820: 8,12
ST   D8S1179: 14,15
ST   FGA: 22
ST   Penta D: 11
ST   Penta E: 5,11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
RX   Patent=CN114606194B;
RA   Xu H., Zhou W.-C., Miao X., Chai C.-P., Tang H.;
RT   "Human intrahepatic bile duct cancer cell strain ICC-X1 and
RT   application thereof.";
RL   Patent number CN114606194B, 09-Jun-2023.
//
RX   PubMed=36578029; DOI=10.1186/s12935-022-02840-3; PMCID=PMC9795767;
RA   Miao X., Hu J.-J., Chai C.-P., Tang H., Zhao Z.-J., Luo W.,
RA   Zhou W.-C., Xu H.;
RT   "Establishment and characterization of a new intrahepatic
RT   cholangiocarcinoma cell line derived from a Chinese patient.";
RL   Cancer Cell Int. 22:418.1-418.13(2022).
//